FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
Through a third-party pharmacy, people interested in the self or caregiver option will complete a screening and eligibility ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
Astra said the FDA-required studies "showed that 100% of intended users administered a full dose. "In addition, data show that efficacy, immunogenicity and adverse events with self-administration of ...
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in ...
The FDA has approved FluMist nasal spray as the first at-home flu vaccine. People aged 18 and older can now self-administer ...
"For those interested in self or caregiver administration, the vaccine manufacturer plans to make the vaccine available ...